Syngene

Syngene are a division of the Synoptics Group, founded in 1985 by imaging experts from the University of Cambridge. At Syngene we live and breathe image analysis because products specifically for gel documentation and fluorescence/chemiluminescence imaging are all we’ve ever focused on developing.

Our other divisions in the Synoptics Group, Synbiosis and Syncroscopy, develop imaging solutions for microbial and microscopy applications so we are complete life science imaging specialists. Synoptics Health focuses on imaging techniques within the clinical environment.

We are headquartered in Cambridge, a thriving scientific hub in the UK and have a centrally located US subsidiary in Frederick, USA. Globally, our products are supported by an international network of over 60 highly-trained distributors, all of whom employ imaging specialists.

Our world-leading technology includes a wide range of equipment for instant gel documentation, automated chemiluminescence imaging and TLC plate reading, which comply with current regulations specified by accreditation bodies and regulatory agencies.

Our systems are used globally by more than 75,000 scientists and you’ll find them successfully contributing accurate data to important projects in many of the world’s top pharmaceutical companies and major research institutes.

Syngene is a division of Synoptics Ltd. Synoptics Ltd is a company registered in England with company number 1874861. Its registered office address is Beacon House, Nuffield Road, Cambridge CB4 1TF. Synoptics Ltd VAT number is GB665 523522.

Synoptics Limited is fully compliant to the Waste Electrical & Electronic Equipment (WEEE) Regulations. We are a Member of the B2B Compliance scheme, which will handle our WEEE obligations on our behalf. Our Product Registration Number is WEE/AJ0049TZ. For further information, please contact B2B Compliance on: +44 (0) 1691 676 124.